Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 63 (7), 619-629
- https://doi.org/10.1016/j.jacc.2013.10.022
Abstract
No abstract availableKeywords
Funding Information
- The Medicines Company
This publication has 19 references indexed in Scilit:
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic EventsThe New England Journal of Medicine, 2013
- Intra-Procedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary SyndromesJACC: Cardiovascular Interventions, 2013
- Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary SyndromesКАРДИОЛОГИЯ УЗБЕКИСТАНА, 2012
- Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trialAmerican Heart Journal, 2012
- Predictors and Implications of Stent Thrombosis in Non–ST-Segment Elevation Acute Coronary SyndromesCirculation: Cardiovascular Interventions, 2011
- Bivalirudin during Primary PCI in Acute Myocardial InfarctionThe New England Journal of Medicine, 2008
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Bivalirudin for Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2006
- Validation of Predictors of Intraprocedural Stent Thrombosis in the Drug-Eluting Stent EraThe American Journal of Cardiology, 2005
- Intraprocedural Stent Thrombosis During Implantation of Sirolimus-Eluting StentsCirculation, 2004